Guided Therapeutics (GTHP) Cash & Current Investments (2010 - 2026)
Guided Therapeutics' (GTHP) quarterly Cash & Current Investments came in at $12000.0 in Q2 2026, down 93.51% year-over-year from $185000.0 in Q2 2025, and down 96.75% quarter-over-quarter from $369000.0 in Q1 2026.
Powered by 
Analysis
Guided Therapeutics (GTHP) Cash & Current Investments (2010 - 2026) Analysis & Trends
Guided Therapeutics has disclosed Cash & Current Investments across 17 years of filings, most recently posting $12000.0 for Q2 2026.
- In Q2 2026, Cash & Current Investments fell 93.51% year-over-year to $12000.0; the TTM figure through Jun 2026 stood at $12000.0 (down 93.51% YoY), while the FY2025 annual figure was $63000.0, down 83.76% from the prior year.
- Cash & Current Investments came in at $12000.0 for Q2 2026 at Guided Therapeutics, down from $369000.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $2.7 million in Q3 2022 to a low of $12000.0 in Q2 2026.
- Average Cash & Current Investments over 5 years is $712833.3, with a median of $416500.0 recorded in 2024.
- Year-over-year, Cash & Current Investments jumped 398.52% in 2022 and slumped 93.51% in 2026.
- Over 5 years, Cash & Current Investments stood at $2.3 million in 2022, then tumbled by 74.45% to $591000.0 in 2023, then plunged by 34.35% to $388000.0 in 2024, then tumbled by 83.76% to $63000.0 in 2025, then tumbled by 80.95% to $12000.0 in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $12000.0 in Q2 2026, $369000.0 in Q1 2026, and $63000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Guided Therapeutics | 19.31 Mn | 19.30 Mn | - | 12,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12,000.00 |
| Mar 31, 2026 | 369,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 388,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 275,000.00 |
| Mar 31, 2024 | 445,000.00 |
| Dec 31, 2023 | 591,000.00 |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 446,000.00 |
| Mar 31, 2022 | 725,000.00 |
| Dec 31, 2021 | 643,000.00 |
| Sep 30, 2021 | 541,000.00 |